Clinical Trial

The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 4, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This research study wants to learn about Chronic Kidney Disease (CKD) with Obesity, and Heart Failure with preserved Ejection Fraction (HFpEF) and better ways to evaluate these diseases. HFpEF means that the heart is not able to fill properly with blood while it is resting so the amount of blood pumped out to the body is less than it would be if it was filling properly. The study is being done to describe the differences in how the kidneys handle protein and salt in participants with HFpEF and obesity compared to healthy persons.
Trial Details
NCT Number NCT07052539
Lead Sponsor University of Mississippi Medical Center
Conditions Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF), Obesity (Disorder)
Enrollment 60 participants
Start Date 2022-07-22
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-04